BioCentury
ARTICLE | Distillery Therapeutics

Boosting Tnip3-mediated inhibition of MAP3K7 for non-alcoholic steatohepatitis

May 26, 2020 7:04 PM UTC

INDICATION: Non-alcoholic steatohepatitis (NASH)...

BCIQ Company Profiles

Wuhan University